NoroxyhydrastinineCAS# 21796-14-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 21796-14-5 | SDF | Download SDF |
PubChem ID | 89047 | Appearance | Powder |
Formula | C10H9NO3 | M.Wt | 191.19 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 7,8-dihydro-6H-[1,3]dioxolo[4,5-g]isoquinolin-5-one | ||
SMILES | C1CNC(=O)C2=CC3=C(C=C21)OCO3 | ||
Standard InChIKey | VSOJKDUWYQCWFM-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C10H9NO3/c12-10-7-4-9-8(13-5-14-9)3-6(7)1-2-11-10/h3-4H,1-2,5H2,(H,11,12) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Noroxyhydrastinine exhibits potent melanogenesis-inhibitory activities, it inhibits melanogenesis, at least in part, by inhibiting the expression of protein levels of tyrosinase, TRP-1, and TRP-2 in α-MSH-stimulated B16 melanoma cells. |
Targets | Tyrosinase | TRP-1 | TRP-2 |
In vitro | Alkaloids from Zuojin Formula and their cytotoxicities against proliferation of cancer cells[Reference: WebLink]《Chinese Traditional and Herbal Drugs》 2014-01To study the alkaloid constituents of Zuojin Formula, consisting of Coptidis Rhizoma and Euodiae Fructus, and to evaluate their cytotoxicities against the proliferation of cancer cells in human digestive tract. Melanogenesis-Inhibitory and Cytotoxic Activities of Limonoids, Alkaloids, and Phenolic Compounds from Phellodendron amurense Bark.[Pubmed: 28425165]Chem Biodivers. 2017 Jul;14(7).Four limonoids, 1 - 4, five alkaloids, 5 - 9, and four phenolic compounds, 10 - 13, were isolated from a MeOH extract of the bark of Phellodendron amurense (Rutaceae). Among these, compound 13 was new, and its structure was established as rel-(1R,2R,3R)-5-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-6-methoxy-1-(methoxycarbonylmethyl)indane-2-carboxylic acid methyl ester (γ-di(methyl ferulate)) based on the spectrometric analysis.
|
Structure Identification | Chemical & pharmaceutical bulletin 30(8), 2793-2796, 1982-08-25Chemical Transformation of Protoberberines. I. Conversion of Tetrahydroberberine and Dihydroberberine into Noroxyhydrastinine by Photooxygenation[Reference: WebLink]Simple and biomimetic conversions of tetrahydroberberine (1) and dihydroberberine (6) into Noroxyhydrastinine (3), an isoquinolone alkaloid, are described. Photooxygenation of 1 afforded berberal (2), 3,and O-methylpseudopianic acid (4). The same products were obtained more efficiently by photooxygenation of 6. Zhong Yao Cai. 2008 Nov;31(11):1656-8.Studies on chemical constituents in the anti-myocardial ischemia effective fraction of Corydalis yanhusuo.[Pubmed: 19260272]To study the chemical constituents in the anti-myocardial ischemia effective fraction of Corydalis yanhusuo.
|
Noroxyhydrastinine Dilution Calculator
Noroxyhydrastinine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.2304 mL | 26.152 mL | 52.304 mL | 104.608 mL | 130.76 mL |
5 mM | 1.0461 mL | 5.2304 mL | 10.4608 mL | 20.9216 mL | 26.152 mL |
10 mM | 0.523 mL | 2.6152 mL | 5.2304 mL | 10.4608 mL | 13.076 mL |
50 mM | 0.1046 mL | 0.523 mL | 1.0461 mL | 2.0922 mL | 2.6152 mL |
100 mM | 0.0523 mL | 0.2615 mL | 0.523 mL | 1.0461 mL | 1.3076 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Homomangiferin
Catalog No.:BCN8145
CAS No.:21794-66-1
- Diallyl disulfide
Catalog No.:BCN3840
CAS No.:2179-57-9
- Curcolonol
Catalog No.:BCN3558
CAS No.:217817-09-9
- 9,16-Dioxo-10,12,14-octadecatrienoic acid
Catalog No.:BCN1490
CAS No.:217810-46-3
- H-Asp(OBzl)-OH
Catalog No.:BCC2885
CAS No.:2177-63-1
- 4-Cadinen-7-ol
Catalog No.:BCN4932
CAS No.:217650-27-6
- BX 471
Catalog No.:BCC6029
CAS No.:217645-70-0
- Taxoquinone
Catalog No.:BCN6660
CAS No.:21764-41-0
- Cyclo(Ala-Tyr)
Catalog No.:BCN2412
CAS No.:21754-26-7
- Cyclo(Tyr-Val)
Catalog No.:BCN2413
CAS No.:21754-25-6
- Tulathromycin A
Catalog No.:BCC2019
CAS No.:217500-96-4
- L-817,818
Catalog No.:BCC7221
CAS No.:217480-27-8
- Thalifoline
Catalog No.:BCN3301
CAS No.:21796-15-6
- Potassium Canrenoate
Catalog No.:BCC3844
CAS No.:2181-04-6
- Isopteleine
Catalog No.:BCN7067
CAS No.:2181-84-2
- SC 26196
Catalog No.:BCC7880
CAS No.:218136-59-5
- SRPIN340
Catalog No.:BCC4849
CAS No.:218156-96-8
- Vindoline
Catalog No.:BCN4933
CAS No.:2182-14-1
- Nifedipine
Catalog No.:BCC4808
CAS No.:21829-25-4
- Macrocarpal K
Catalog No.:BCN4934
CAS No.:218290-59-6
- BDNF (human)
Catalog No.:BCC5944
CAS No.:218441-99-7
- Octahydroisoindole
Catalog No.:BCN2275
CAS No.:21850-12-4
- Falcarinol
Catalog No.:BCN3938
CAS No.:21852-80-2
- Bardoxolone
Catalog No.:BCC1399
CAS No.:218600-44-3
Melanogenesis-Inhibitory and Cytotoxic Activities of Limonoids, Alkaloids, and Phenolic Compounds from Phellodendron amurense Bark.[Pubmed:28425165]
Chem Biodivers. 2017 Jul;14(7).
Four limonoids, 1 - 4, five alkaloids, 5 - 9, and four phenolic compounds, 10 - 13, were isolated from a MeOH extract of the bark of Phellodendron amurense (Rutaceae). Among these, compound 13 was new, and its structure was established as rel-(1R,2R,3R)-5-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-6-methoxy-1-(methoxycarbon ylmethyl)indane-2-carboxylic acid methyl ester (gamma-di(methyl ferulate)) based on the spectrometric analysis. Upon evaluation of compounds 1 - 13 against the melanogenesis in the B16 melanoma cells induced with alpha-melanocyte-stimulating hormone (alpha-MSH), four compounds, limonin (1), Noroxyhydrastinine (6), haplopine (7), and 4-methoxy-1-methylquinolin-2(1H)-one (8), exhibited potent melanogenesis-inhibitory activities with almost no toxicity to the cells. Western blot analysis revealed that compound 6 inhibited melanogenesis, at least in part, by inhibiting the expression of protein levels of tyrosinase, TRP-1, and TRP-2 in alpha-MSH-stimulated B16 melanoma cells. In addition, when compounds 1 - 13 were evaluated for their cytotoxic activities against leukemia (HL60), lung (A549), duodenum (AZ521), and breast (SK-BR-3) cancer cell lines, five compounds, berberine (5), 8, canthin-6-one (9), alpha-di-(methyl ferulate) (12), and 13, exhibited cytotoxicities against one or more cancer cell lines with IC50 values in the range of 2.6 - 90.0 mum. In particular, compound 5 exhibited strong cytotoxicity against AZ521 (IC50 2.6 mum) which was superior to that of the reference cisplatin (IC50 9.5 mum).
[Studies on chemical constituents in the anti-myocardial ischemia effective fraction of Corydalis yanhusuo].[Pubmed:19260272]
Zhong Yao Cai. 2008 Nov;31(11):1656-8.
OBJECTIVE: To study the chemical constituents in the anti-myocardial ischemia effective fraction of Corydalis yanhusuo. METHODS: Compounds were isolated and purified by a macroporous resin, Sephadex LH-20, ODS column chromatography, and prepared TLC. Their structures were identified by spectral analysis and chemical evidence. RESULTS: Nine compounds, tetrahydrocolumbamine (1), Noroxyhydrastinine (2), corunine (3), dehydrocorydaline (4), dehydrocorybulbine (5), columbamine (6), coptisine (7), berberine (8), palmatine (9) were isolated and identified from the effective fraction of Corydalis yanhusuo. CONCLUSION: Compounds 2, 3 and 5 were isolated from this plant for the first time.